ClinicalTrials.gov record NCT06339957
Rheumatology Diet Study
Title of Study: Eating Habits and Symptom Severity in Autoimmune Diseases: a Patient Survey
AI summaryWhat this study is about, in plain languageShow ▾Hide ▴
AI-written from the registry record, not the study's own wording. May contain errors or omissions. Check the registry text on this page and the original record ↗ before acting on it.
This is a cross-sectional survey study of UCF Health rheumatology patients about their diets and disease symptoms. It asks whether patients changed eating habits after an autoimmune diagnosis, what resources they used, and whether they felt symptoms changed. The study is based on a one-time questionnaire and analysis of responses. The study population is described as adult UCF Health rheumatology patients (ages 18–65).
What it is studying. The study is asking whether people with rheumatologic or autoimmune conditions change their diets after diagnosis, what resources and expectations they have about dietary advice from their rheumatologist, how willing they are to try dietary changes, and whether they report subjective changes in their disease symptoms after changing diet.
What the researchers hope to learn. To describe how diet habits relate to self-reported symptom severity in people with rheumatologic or autoimmune diseases. To identify whether and how patients change diets after diagnosis and whether they report symptom changes. To document patients' expectations of rheumatology care around diet and the resources they use when changing eating habits.
What this study is about
The study's own summary, as published on ClinicalTrials.gov. Underlined terms have a short explanation.
This study aims to collect information on rheumatology patients' dietary habits, autoimmune disease activity, dietary changes, disease symptom improvements, and perceptions on their dietary habits and how it affects their autoimmune disease. The main objective is to see if rheumatology patients change their dietary habits after their diagnosis of an autoimmune disease and if it subjectively improved their disease symptoms. It will also look at rheumatology patients' expectations for their rheumatologist when it comes to dietary advice and what resources they used to choose their new dietary habits. The study also seeks to measure the interest that rheumatology patients have in pursuing dietary changes as a means of controlling the symptoms of their autoimmune disease. It is expected that patients who changed their eating habits to healthier diets such as a Mediterranean diet would report less severe autoimmune disease symptoms. There are limited dietary recommendations for the management of many rheumatological diseases, so this study seeks to assess rheumatology patients' willingness to try dietary modifications, what improvements they had, and why they decide to make these changes in light of limited information.
Eligibility
The criteria exactly as listed on ClinicalTrials.gov. Only the study team can say whether they apply to you.
Inclusion criteria
- Adults (over 18 years old) patients
- established UCF Health patients
- diagnosed with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, dermatomyositis/polymyositis, Sjogren's Syndrome, systemic lupus erythematous, scleroderma, osteoarthritis, or fibromyalgia.
Exclusion criteria
- UCF Students, Faculty or Staff
- Children or Young Adults Under the age of 18
- Adults over 65
- Pregnant Women
- Prisoners
- Adults to Unable to Consent
Study description and what participation involves
The registry record has no detailed description beyond the summary above.
AI summaryWhat participation may involve, in plain languageShow ▾Hide ▴
AI-written from the registry record, not the study's own wording. May contain errors or omissions. Check the registry text on this page and the original record ↗ before acting on it.
If eligible, people identified from the UCF Health rheumatology records would be asked to complete a survey about their eating habits, any diet changes since diagnosis, symptom severity and changes, expectations about dietary advice from their rheumatologist, and resources used to choose diets. The study is a cross-sectional patient survey (no experimental treatment). No invasive procedures are listed in the registry. Participation requires the ability to provide informed consent; pregnant people, prisoners, and UCF students/staff are not eligible.
How the study is structured. A one-time, observational survey (cross-sectional, case-only). Researchers identify eligible patients from the UCF Health rheumatology patient list, invite them to complete questionnaires, and analyze the answers using statistical tests such as t-tests and ANOVA.
Questions you could ask
These questions are suggestions for a conversation with the study team or your own clinician, not advice.
- This is an observational study, so the study itself gives no treatment. What would taking part involve for me, and would it change my usual care?
- The listed sites are in United States. Is any of them reachable for me, and does the study help with travel?
- Which of the eligibility criteria would need to be checked with tests before I could join?
More on polymyositis
This trial is also listed on this site under dermatomyositis.
Important dates
- Study start
- Mar 1, 2024
- Primary completion
- Jul 1, 2025 (estimated)
- Study completion
- Jul 1, 2025 (estimated)
- Target enrollment
- 500 participants (estimated)
- Last updated on registry
- Dec 6, 2024
- Data verified
- Oct 10, 2026
Sponsor and research team
The lead sponsor funds and oversees the trial. A pharmaceutical or biotech company sponsor typically means the study is testing that company's drug or device; a hospital, university, or government agency usually indicates investigator-initiated or publicly funded research.
- Lead sponsor
- University of Central Florida
Central study contact
If you're interested in participating, the central contact can answer general questions about the study — including eligibility requirements and how to find a recruiting site near you. Actual eligibility is determined by the site's medical team.
- Amoy Fraser, PhD, CCRP, PMP 📞 407-266-8742 ✉ amoy.fraser@ucf.edu
- Erica Martin, B.S. 📞 407-266-8742 ✉ erica.martin@ucf.edu
Participating sites (1)
- UCF Health ClinicsRecruiting
Orlando, Florida, 32827 · United States
Terms used on this page · explanations by MedicalUpdates.ai
- Inclusion Criteria
- The conditions a person must meet to be considered for the study, for example a confirmed diagnosis, an age range or a test result.
- Exclusion Criteria
- The conditions that rule a person out even if they meet the inclusion criteria, for example other illnesses, certain medicines or pregnancy.
The study record on this page is reproduced from ClinicalTrials.gov, a database of the U.S. National Library of Medicine, where it was submitted by the study sponsor. MedicalUpdates.ai does not own this content, is not affiliated with or endorsed by ClinicalTrials.gov, NIH, or the U.S. Government, and does not verify the record. Plain-language notes, the glossary and the questions above are added by this site; text in the boxes marked "AI summary" was written by an AI model and may contain errors. Registry records change over time. Check the original record for the current version and discuss eligibility or participation with a qualified healthcare professional.
← Back to clinical trials